Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology.
• 1,400+ highly qualified professionals
• Global full-service CRO
• 25+ years of experience
• Therapeutic specialization in oncology
• Strong expertise in rare disease trials
• Robust clinical safety system
• Choice of leading drug safety databases
Our key services include:
• Clinical Research Services
• Pharmacovigilance
• Medical Information
• Regulatory
• Medical Writing
• Site Management
• Study Physician Support
• Biostatistics
• Patient Study Support
Company’s Keywords:
oncology, neurology, respiratory diseases, orphan drugs, metabolic diseases, clinical trials, cro, contract research organization, rare diseases, phase iv, drug development, pharmaceuticals, biotechnology, pharmacovigilance, covid 19, clinical safety, medical information, allergy
540
pharmaceuticals
117307000
Outlook, Microsoft Office 365, Amazon AWS, Atlassian Cloud, Nginx, Google Tag Manager, WordPress.org, reCAPTCHA, Mobile Friendly, Shutterstock, Google Maps (Non Paid Users), Google Maps, Gravity Forms, Apache, Google Font API, YouTube, Bootstrap Framework
1997